Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C87346
http://purl.obolibrary.org/obo/NCIT_C87346
|
|---|---|
| Preferred Name | Sodium Selenite |
| Definitions |
An inorganic form of the trace element selenium with potential antineoplastic activity. Selenium, administered in the form of sodium selenite, is reduced to hydrogen selenide (H2Se) in the presence of glutathione (GSH) and subsequently generates superoxide radicals upon reaction with oxygen. This may inhibit the expression and activity of the transcription factor Sp1; in turn Sp1 down-regulates androgen receptor (AR) expression and blocks AR signaling. Eventually, selenium may induce apoptosis in prostate cancer cells and inhibit tumor cell proliferation.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An inorganic form of the trace element selenium with potential antineoplastic activity. Selenium, administered in the form of sodium selenite, is reduced to hydrogen selenide (H2Se) in the presence of glutathione (GSH) and subsequently generates superoxide radicals upon reaction with oxygen. This may inhibit the expression and activity of the transcription factor Sp1; in turn Sp1 down-regulates androgen receptor (AR) expression and blocks AR signaling. Eventually, selenium may induce apoptosis in prostate cancer cells and inhibit tumor cell proliferation. |
|---|---|
| prefLabel | Sodium Selenite
|
| label | Sodium Selenite
|
| CHEBI_ID | CHEBI:48843
|
| PDQ_Closed_Trial_Search_ID | 681583
|
| code | C87346
|
| prefixIRI | NCIT:C87346
|
| in_subset |
See more
See less
|
| Display_Name | Sodium Selenite
|
| Preferred_Name | Sodium Selenite
|
| FDA_UNII_Code | HIW548RQ3W
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | 2Na.O3Se
|
| Maps_To | Sodium Selenite
|
| CAS_Registry | 10102-18-8
|
| NCI_Drug_Dictionary_ID | 681583
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 681583
|
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C0142923
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |